----
10X Genomics (TXG)
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
10X Genomics Analyst Rating
View moreForecast & Rating
Oct 26, 2026Price forecast
$77.506.22%
Forecast & RatingBuy
18analysts
- Strong buy27.78%
- Buy5.56%
- Hold66.67%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 5
- Buy
- 1
- Hold
- 12
- Sell
- 0
- Strong sell
- 0
News
Weekly Review · Weekly Recap | 10X Genomics +2.42%, most brokers rate it buy
Weekly Review · Weekly Recap | 10X Genomics -13.38%, consensus target above spot
Weekly Review · Weekly Recap | 10X Genomics -13.74%, CEO sale meets overvaluation warning
Weekly Review · Weekly Recap | 10X Genomics +9.09%, price above most broker targets
Weekly Review · Weekly Recap | 10X Genomics +11.89%, closing in on record highs
Weekly Review · Weekly Recap | 10X Genomics +11.68%, consensus target below spot
